Immunic Inc (NASDAQ:IMUX)
| 15.86 Delayed Data As of 3:59pm ET |  +0.22 / +1.41%Today’s Change | 4.19 Today|||52-Week Range 28.21 | +3.73% Year-to-Date |
Latest IMUX News | Press Releases
No recent news for Immunic Inc.
Today’s Trading
| Previous close | 15.64 |
| Today’s open | 15.55 |
| Day’s range | 15.00 - 16.14 |
| Volume | 18,463 |
| Average volume (3 months) | 271,790 |
| Market cap | $350.1M |
Data as of 3:59pm ET, 02/26/2021
Growth & Valuation
| Earnings growth (last year) | +88.45% |
| Earnings growth (this year) | +32.88% |
| Earnings growth (next 5 years) | +15.51% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.11 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABUSArbutus Biopharma Co... | -0.08 | -2.10% |
| ONCTOncternal Therapeuti... | -0.21 | -3.10% |
| PRTKParatek Pharmaceutic... | +0.17 | +2.32% |
| AMPEAmpio Pharmaceutical... | +0.02 | +1.18% |
Data as of 3:59pm ET, 02/26/2021
Financials
| Next reporting date | March 22, 2021 |
| EPS forecast (this quarter) | -$0.68 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$34.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
